“Visfatin Promotes Renal Cell Carcinoma Progression: Evidence from Clinical Samples and Cell Line Models”, jkcvhl, vol. 12, no. 3, pp. 58–65, Sep. 2025, doi: 10.15586/jkcvhl.v12i3.427.